Evidence map›Paper›PMID 36325253›Full record

ArticlePreventive medicine reports2022

Neighborhood distribution of availability of newer tobacco products: A US four-site study, 2021.

Shyanika W Rose, Arati Annabathula, Susan Westneat, Judy van de Venne, Mary Hrywna, Christopher Ackerman, Joseph G L Lee, Mahdi Sesay, Daniel P Giovenco, Torra Spillane and 2 more

Abstract read
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Retail Availability of Oral Nicotine Pouches in Three US Cities: A Geographic Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  5. Review
  6. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shyanika W RoseUniversity of Kentucky, College of Medicine, Behavioral Science and Center for Health Equity Transformation, Lexington, KY, USA.
Arati AnnabathulaUniversity of Kentucky, College of Medicine, Behavioral Science and Center for Health Equity Transformation, Lexington, KY, USA.
Susan WestneatUniversity of Kentucky, College of Medicine, Behavioral Science and Center for Health Equity Transformation, Lexington, KY, USA.
Judy van de VenneUniversity of Kentucky, College of Medicine, Behavioral Science and Center for Health Equity Transformation, Lexington, KY, USA.
Mary HrywnaRutgers Center for Tobacco Studies, New Brunswick, NJ, USA.
Christopher AckermanRutgers Center for Tobacco Studies, New Brunswick, NJ, USA.
Joseph G L LeeDepartment of Health Education and Promotion, College of Health and Human Performance, East Carolina University, Greenville, NC, USA.
Mahdi SesayDepartment of Health Education and Promotion, College of Health and Human Performance, East Carolina University, Greenville, NC, USA.
Daniel P GiovencoDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York City, NY, USA.
Torra SpillaneDepartment of Sociomedical Sciences, Columbia University Mailman School of Public Health, New York City, NY, USA.
Shawna V HudsonDept of Family Medicine and Community Health, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.
Cristine D DelnevoRutgers Center for Tobacco Studies, New Brunswick, NJ, USA.

Funding

INSTITUTIONAL RESEARCH CANCER EPIDEMIOLOGY FELLOWSHIPT32CA009314 · NCI · JOHNS HOPKINS UNIVERSITY · PI Corinne E. Joshu, Meghan Bridgid Moran · 1985 to 2026
$11.2M
Evaluating implementation of Tobacco 21 laws in the U.S.R01CA231139 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Maria Hrywna, Amanda Kong · 2018 to 2026
$4.7M
NCI NIH HHS R01 CA231139NCI NIH HHS T32 CA009314
6 · The paper itself

Abstract

Audits of tobacco retailers can identify marketing patterns as newer tobacco products are introduced in the US. Our study examined store and neighborhood correlates of availability of nicotine pouches and disposable e-cigarettes in four US sites. We conducted standardized store audits of n = 242 tobacco retailers in 2021 in different states: New Jersey, Kentucky, North Carolina, and New York. We geocoded stores linking them with census tract demographics. We conducted unadjusted and adjusted Poisson regression of availability of each product with correlates of the proportion of Non-Hispanic White residents, households under poverty, proximity to schools, site, and store type. Nicotine pouches and disposable e-cigarettes were each available in around half the stores overall, but availability differed across sites (range: 76 %-32 %). In adjusted analyses, nicotine pouches were less likely to be available in each store type vs chain convenience (IRR range 0.2-0.6) and more likely in stores in census tracts with a greater percentage of non-Hispanic White residents (IRR range 1.8-2.3). In contrast, disposable e-cigarettes were more likely to be available in tobacco/vape shops (IRR 1.9 (1.4-2.5) than convenience stores and less likely in non-specialty store types like groceries (IRR 0.2 (0.1-0.4). Newer tobacco products like nicotine pouches and disposable e-cigarettes were widely available in stores across sites, but retail marketing patterns appear to differ. As these product types become subject to increased regulation as they go through the FDA pre-market authorization process, understanding patterns and changes in the retail environment is critical to inform potential policies regulating their sale and marketing.

Indexed as

MarketingRetailTFNP, Tobacco-Free Nicotine PouchTobacco controlTobacco products

Identifiers

PMID36325253
PMCPMC9619027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.